YOSHIO YAMAOKA to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Randomized Controlled Trials as Topic.
Connection Strength
0.381
-
Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for Helicobacter pylori eradication: a systematic review and network meta-analysis. BMJ Open Gastroenterol. 2026 Jan 14; 13(1).
Score: 0.169
-
Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis. World J Gastroenterol. 2020 Apr 21; 26(15):1820-1840.
Score: 0.114
-
Helicobacter pylori therapy and clinical perspective. J Glob Antimicrob Resist. 2018 09; 14:111-117.
Score: 0.098